What is the detailed management of severe dengue infection?

Management of Complicated Dengue

Judicious fluid resuscitation is the cornerstone of severe dengue management, with crystalloids as first-line therapy and colloids reserved for severe dengue shock syndrome (pulse pressure <10 mmHg) in children, while avoiding fluid overload that can lead to fatal complications 1.

Initial Assessment and Monitoring

Severe dengue requires immediate recognition and aggressive supportive care. Monitor for:

• Plasma leakage indicators: Rising hematocrit with falling platelet count, pleural effusion, ascites
• Severe bleeding: Despite often normal platelet counts
• Organ impairment: Hepatic (AST/ALT >1000), neurological (altered consciousness, seizures), cardiac, or renal dysfunction
• Shock parameters: Narrow pulse pressure (<20 mmHg), cold extremities, prolonged capillary refill (>3 seconds), weak pulses, altered mental status, oliguria

Fluid Management Algorithm

Phase 1: Initial Resuscitation (Critical Phase)

For patients with warning signs or compensated shock:

• Start with crystalloid bolus 10-20 mL/kg over 1 hour 2, 1
• Reassess after each bolus - this is mandatory 3
• Monitor for hepatomegaly, rales, or respiratory distress indicating fluid overload
• Continue liberal fluids for 24-48 hours during plasma leakage phase 1

For severe dengue shock (pulse pressure <10 mmHg):

• Consider colloid solutions (gelatin, dextran, or albumin) in children 1
• Colloids show benefit for time to resolution of shock in severe cases 3
• In moderate shock (pulse pressure 10-20 mmHg), crystalloids and colloids have similar outcomes 1

Phase 2: Fluid-Refractory Shock

If tissue hypoperfusion persists despite aggressive fluid resuscitation:

• Initiate dopamine or epinephrine (adrenaline) 1
• Start peripheral inotropic support immediately if central access unavailable - do not delay 2
• Monitor blood pressure and heart rate frequently 1
• Consider hydrocortisone up to 300 mg/day (or prednisolone 75 mg/day) in adults requiring escalating vasopressor doses 1

Critical differentiation:

• Cardiogenic shock: Cool extremities, distended neck veins, crackles, third/fourth heart sound → requires inotropes
• Distributive shock: Warm extremities, oliguria, altered mental status → requires vasopressors
• Exclude obstructive causes: pneumothorax, pericardial tamponade, abdominal compartment syndrome 1

Phase 3: De-resuscitation (Recovery Phase)

Once plasma leakage stops (typically 48-72 hours after defervescence):

• Actively reduce fluid administration to prevent pulmonary edema and pleural effusion
• Monitor for signs of fluid overload: respiratory distress, oxygen desaturation, increasing pleural effusions
• Consider diuretics if fluid overload develops

Respiratory Support

• Oxygen therapy: Target SpO2 >90% 1
• Semi-recumbent position: Head of bed elevated 30-45° 1
• Unconscious patients: Lateral position with clear airway 1
• Non-invasive ventilation: Consider if trained staff available and persistent hypoxemia despite oxygen 1

Transfusion Thresholds

Platelet transfusion is NOT prophylactic 4:

• Only transfuse for active bleeding with thrombocytopenia
• Platelet count alone does not determine transfusion need
• Focus on clinical bleeding rather than laboratory values

Blood transfusion:

• For severe anemia (hemoglobin <4 g/dL) with hemodynamic compromise
• Particularly important in children with severe malaria or sickle cell crisis presenting with dengue-like illness 2

Organ-Specific Complications

Hepatic involvement (most common):

• Monitor transaminases, coagulation profile
• Supportive care; avoid hepatotoxic medications

Neurological complications:

• Dengue encephalopathy/encephalitis requires ICU monitoring
• Manage seizures, cerebral edema per standard protocols

Secondary hemophagocytic lymphohistiocytosis:

• Potentially fatal complication requiring recognition
• Consider steroids or IVIG if diagnosed 4

Critical Pitfalls to Avoid

1. Over-resuscitation: More dangerous than under-resuscitation in dengue due to plasma leakage physiology. Stop fluids when hepatomegaly or rales develop 2, 1

2. Resource-limited settings: In settings without mechanical ventilation and inotropic support, aggressive fluid boluses may increase mortality 3. Use maintenance fluids with extreme caution in these contexts.

3. Antibiotics: Dengue is viral - do not routinely administer antibiotics unless bacterial co-infection suspected 1

4. Timing: The critical phase (days 3-7 of illness) requires most intensive monitoring. Missing this window increases mortality.

5. Inadequate monitoring: Reassess after every intervention. Clinical endpoints (capillary refill, peripheral pulses, mental status, urine output >0.5 mL/kg/hour) are more reliable than blood pressure alone 1

Monitoring Endpoints

Adequate tissue perfusion achieved when:

• Normal capillary refill time (<3 seconds)
• Absence of skin mottling
• Warm, dry extremities
• Well-felt peripheral pulses
• Return to baseline mental status
• Urine output >0.5 mL/kg/hour (adults) or >1 mL/kg/hour (children) 1

The evidence strongly supports that crystalloids remain first-line for most dengue cases, with selective colloid use only in severe pediatric dengue shock syndrome 1, 3. The key to reducing mortality is recognizing the critical phase early, providing adequate but not excessive fluid resuscitation, and transitioning to de-resuscitation once plasma leakage resolves 5, 6, 4, 7.